Tuesday Afternoon Sessions Continue to Tantalize Attendees
The joint session with OTIS on Cancer and Pregnancy: Considerations regarding the Use of Chemotherapy will begin at 2:45 pm. The goal of this symposium is to explore the current diagnostic and systemic treatment regimens used to treat breast cancer in pregnant patients, discuss a current registry effort to assess the pregnancy outcomes in pregnant women with cancer, and briefly review the National Toxicology Program’s recent evaluation of developmental effects and pregnancy outcomes associated with treatment with cancer chemotherapy during pregnancy. Finally, the symposium will conclude with a presentation on the latest methods of fertility preservation in patients with cancer.
The In Vitro, Computational, and Alternative Methods and Models for Screening Developmental Toxicants platform session will feature seven presentations. This session will begin at 2:45 pm and includes a schedule adjustment.